Anthelmintic Drugs Market
1 Study Coverage
1.1 Anthelmintic Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Anthelmintic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral Drugs
1.2.3 Injectables
1.3 Market by Application
1.3.1 Global Anthelmintic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 For Human
1.3.3 For Animal
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anthelmintic Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Anthelmintic Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Anthelmintic Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Anthelmintic Drugs Sales by Region
2.4.1 Global Anthelmintic Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Anthelmintic Drugs by Region (2023-2028)
2.5 Global Anthelmintic Drugs Revenue by Region
2.5.1 Global Anthelmintic Drugs Revenue by Region (2017-2022)
2.5.2 Global Anthelmintic Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Anthelmintic Drugs Sales by Manufacturers
3.1.1 Global Top Anthelmintic Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Anthelmintic Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anthelmintic Drugs in 2021
3.2 Global Anthelmintic Drugs Revenue by Manufacturers
3.2.1 Global Anthelmintic Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Anthelmintic Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Anthelmintic Drugs Revenue in 2021
3.3 Global Anthelmintic Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Anthelmintic Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anthelmintic Drugs Sales by Type
4.1.1 Global Anthelmintic Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Anthelmintic Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Anthelmintic Drugs Sales Market Share by Type (2017-2028)
4.2 Global Anthelmintic Drugs Revenue by Type
4.2.1 Global Anthelmintic Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Anthelmintic Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Anthelmintic Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Anthelmintic Drugs Price by Type
4.3.1 Global Anthelmintic Drugs Price by Type (2017-2022)
4.3.2 Global Anthelmintic Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Anthelmintic Drugs Sales by Application
5.1.1 Global Anthelmintic Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Anthelmintic Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Anthelmintic Drugs Sales Market Share by Application (2017-2028)
5.2 Global Anthelmintic Drugs Revenue by Application
5.2.1 Global Anthelmintic Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Anthelmintic Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Anthelmintic Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Anthelmintic Drugs Price by Application
5.3.1 Global Anthelmintic Drugs Price by Application (2017-2022)
5.3.2 Global Anthelmintic Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Anthelmintic Drugs Market Size by Type
6.1.1 North America Anthelmintic Drugs Sales by Type (2017-2028)
6.1.2 North America Anthelmintic Drugs Revenue by Type (2017-2028)
6.2 North America Anthelmintic Drugs Market Size by Application
6.2.1 North America Anthelmintic Drugs Sales by Application (2017-2028)
6.2.2 North America Anthelmintic Drugs Revenue by Application (2017-2028)
6.3 North America Anthelmintic Drugs Market Size by Country
6.3.1 North America Anthelmintic Drugs Sales by Country (2017-2028)
6.3.2 North America Anthelmintic Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Anthelmintic Drugs Market Size by Type
7.1.1 Europe Anthelmintic Drugs Sales by Type (2017-2028)
7.1.2 Europe Anthelmintic Drugs Revenue by Type (2017-2028)
7.2 Europe Anthelmintic Drugs Market Size by Application
7.2.1 Europe Anthelmintic Drugs Sales by Application (2017-2028)
7.2.2 Europe Anthelmintic Drugs Revenue by Application (2017-2028)
7.3 Europe Anthelmintic Drugs Market Size by Country
7.3.1 Europe Anthelmintic Drugs Sales by Country (2017-2028)
7.3.2 Europe Anthelmintic Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anthelmintic Drugs Market Size by Type
8.1.1 Asia Pacific Anthelmintic Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Anthelmintic Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Anthelmintic Drugs Market Size by Application
8.2.1 Asia Pacific Anthelmintic Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Anthelmintic Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Anthelmintic Drugs Market Size by Region
8.3.1 Asia Pacific Anthelmintic Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Anthelmintic Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Anthelmintic Drugs Market Size by Type
9.1.1 Latin America Anthelmintic Drugs Sales by Type (2017-2028)
9.1.2 Latin America Anthelmintic Drugs Revenue by Type (2017-2028)
9.2 Latin America Anthelmintic Drugs Market Size by Application
9.2.1 Latin America Anthelmintic Drugs Sales by Application (2017-2028)
9.2.2 Latin America Anthelmintic Drugs Revenue by Application (2017-2028)
9.3 Latin America Anthelmintic Drugs Market Size by Country
9.3.1 Latin America Anthelmintic Drugs Sales by Country (2017-2028)
9.3.2 Latin America Anthelmintic Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Anthelmintic Drugs Market Size by Type
10.1.1 Middle East and Africa Anthelmintic Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Anthelmintic Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Anthelmintic Drugs Market Size by Application
10.2.1 Middle East and Africa Anthelmintic Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Anthelmintic Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Anthelmintic Drugs Market Size by Country
10.3.1 Middle East and Africa Anthelmintic Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Anthelmintic Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Anthelmintic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis Anthelmintic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Anthelmintic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Anthelmintic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Bayer
11.3.1 Bayer Corporation Information
11.3.2 Bayer Overview
11.3.3 Bayer Anthelmintic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bayer Anthelmintic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bayer Recent Developments
11.4 Cipla
11.4.1 Cipla Corporation Information
11.4.2 Cipla Overview
11.4.3 Cipla Anthelmintic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Cipla Anthelmintic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cipla Recent Developments
11.5 Sun Pharmaceutical Industries
11.5.1 Sun Pharmaceutical Industries Corporation Information
11.5.2 Sun Pharmaceutical Industries Overview
11.5.3 Sun Pharmaceutical Industries Anthelmintic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sun Pharmaceutical Industries Anthelmintic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sun Pharmaceutical Industries Recent Developments
11.6 Mankind Pharma
11.6.1 Mankind Pharma Corporation Information
11.6.2 Mankind Pharma Overview
11.6.3 Mankind Pharma Anthelmintic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Mankind Pharma Anthelmintic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Mankind Pharma Recent Developments
11.7 Johnson & Johnson
11.7.1 Johnson & Johnson Corporation Information
11.7.2 Johnson & Johnson Overview
11.7.3 Johnson & Johnson Anthelmintic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Johnson & Johnson Anthelmintic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Johnson & Johnson Recent Developments
11.8 Merck
11.8.1 Merck Corporation Information
11.8.2 Merck Overview
11.8.3 Merck Anthelmintic Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Merck Anthelmintic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Merck Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anthelmintic Drugs Industry Chain Analysis
12.2 Anthelmintic Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anthelmintic Drugs Production Mode & Process
12.4 Anthelmintic Drugs Sales and Marketing
12.4.1 Anthelmintic Drugs Sales Channels
12.4.2 Anthelmintic Drugs Distributors
12.5 Anthelmintic Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Anthelmintic Drugs Industry Trends
13.2 Anthelmintic Drugs Market Drivers
13.3 Anthelmintic Drugs Market Challenges
13.4 Anthelmintic Drugs Market Restraints
14 Key Findings in The Global Anthelmintic Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Anthelmintic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Oral Drugs
Table 3. Major Manufacturers of Injectables
Table 4. Global Anthelmintic Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Anthelmintic Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Anthelmintic Drugs Sales by Region (2017-2022) & (K Units)
Table 7. Global Anthelmintic Drugs Sales Market Share by Region (2017-2022)
Table 8. Global Anthelmintic Drugs Sales by Region (2023-2028) & (K Units)
Table 9. Global Anthelmintic Drugs Sales Market Share by Region (2023-2028)
Table 10. Global Anthelmintic Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Anthelmintic Drugs Revenue Market Share by Region (2017-2022)
Table 12. Global Anthelmintic Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Anthelmintic Drugs Revenue Market Share by Region (2023-2028)
Table 14. Global Anthelmintic Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Anthelmintic Drugs Sales Share by Manufacturers (2017-2022)
Table 16. Global Anthelmintic Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Anthelmintic Drugs Revenue Share by Manufacturers (2017-2022)
Table 18. Anthelmintic Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
Table 19. Global Anthelmintic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Anthelmintic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anthelmintic Drugs as of 2021)
Table 21. Anthelmintic Drugs Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Anthelmintic Drugs Product Offered
Table 23. Date of Manufacturers Enter into Anthelmintic Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anthelmintic Drugs Sales by Type (2017-2022) & (K Units)
Table 26. Global Anthelmintic Drugs Sales by Type (2023-2028) & (K Units)
Table 27. Global Anthelmintic Drugs Sales Share by Type (2017-2022)
Table 28. Global Anthelmintic Drugs Sales Share by Type (2023-2028)
Table 29. Global Anthelmintic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Anthelmintic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Anthelmintic Drugs Revenue Share by Type (2017-2022)
Table 32. Global Anthelmintic Drugs Revenue Share by Type (2023-2028)
Table 33. Anthelmintic Drugs Price by Type (2017-2022) & (USD/Unit)
Table 34. Global Anthelmintic Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
Table 35. Global Anthelmintic Drugs Sales by Application (2017-2022) & (K Units)
Table 36. Global Anthelmintic Drugs Sales by Application (2023-2028) & (K Units)
Table 37. Global Anthelmintic Drugs Sales Share by Application (2017-2022)
Table 38. Global Anthelmintic Drugs Sales Share by Application (2023-2028)
Table 39. Global Anthelmintic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Anthelmintic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Anthelmintic Drugs Revenue Share by Application (2017-2022)
Table 42. Global Anthelmintic Drugs Revenue Share by Application (2023-2028)
Table 43. Anthelmintic Drugs Price by Application (2017-2022) & (USD/Unit)
Table 44. Global Anthelmintic Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
Table 45. North America Anthelmintic Drugs Sales by Type (2017-2022) & (K Units)
Table 46. North America Anthelmintic Drugs Sales by Type (2023-2028) & (K Units)
Table 47. North America Anthelmintic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Anthelmintic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Anthelmintic Drugs Sales by Application (2017-2022) & (K Units)
Table 50. North America Anthelmintic Drugs Sales by Application (2023-2028) & (K Units)
Table 51. North America Anthelmintic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Anthelmintic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Anthelmintic Drugs Sales by Country (2017-2022) & (K Units)
Table 54. North America Anthelmintic Drugs Sales by Country (2023-2028) & (K Units)
Table 55. North America Anthelmintic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Anthelmintic Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Anthelmintic Drugs Sales by Type (2017-2022) & (K Units)
Table 58. Europe Anthelmintic Drugs Sales by Type (2023-2028) & (K Units)
Table 59. Europe Anthelmintic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Anthelmintic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Anthelmintic Drugs Sales by Application (2017-2022) & (K Units)
Table 62. Europe Anthelmintic Drugs Sales by Application (2023-2028) & (K Units)
Table 63. Europe Anthelmintic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Anthelmintic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Anthelmintic Drugs Sales by Country (2017-2022) & (K Units)
Table 66. Europe Anthelmintic Drugs Sales by Country (2023-2028) & (K Units)
Table 67. Europe Anthelmintic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Anthelmintic Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Anthelmintic Drugs Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Anthelmintic Drugs Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Anthelmintic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Anthelmintic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Anthelmintic Drugs Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Anthelmintic Drugs Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Anthelmintic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Anthelmintic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Anthelmintic Drugs Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Anthelmintic Drugs Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Anthelmintic Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Anthelmintic Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Anthelmintic Drugs Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Anthelmintic Drugs Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Anthelmintic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Anthelmintic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Anthelmintic Drugs Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Anthelmintic Drugs Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Anthelmintic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Anthelmintic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Anthelmintic Drugs Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Anthelmintic Drugs Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Anthelmintic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Anthelmintic Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Anthelmintic Drugs Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Anthelmintic Drugs Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Anthelmintic Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Anthelmintic Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Anthelmintic Drugs Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Anthelmintic Drugs Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Anthelmintic Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Anthelmintic Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Anthelmintic Drugs Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Anthelmintic Drugs Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Anthelmintic Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Anthelmintic Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 105. Novartis Corporation Information
Table 106. Novartis Description and Major Businesses
Table 107. Novartis Anthelmintic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 108. Novartis Anthelmintic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Novartis Recent Developments
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Major Businesses
Table 112. Pfizer Anthelmintic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. Pfizer Anthelmintic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Pfizer Recent Developments
Table 115. Bayer Corporation Information
Table 116. Bayer Description and Major Businesses
Table 117. Bayer Anthelmintic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. Bayer Anthelmintic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Bayer Recent Developments
Table 120. Cipla Corporation Information
Table 121. Cipla Description and Major Businesses
Table 122. Cipla Anthelmintic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Cipla Anthelmintic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Cipla Recent Developments
Table 125. Sun Pharmaceutical Industries Corporation Information
Table 126. Sun Pharmaceutical Industries Description and Major Businesses
Table 127. Sun Pharmaceutical Industries Anthelmintic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. Sun Pharmaceutical Industries Anthelmintic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Sun Pharmaceutical Industries Recent Developments
Table 130. Mankind Pharma Corporation Information
Table 131. Mankind Pharma Description and Major Businesses
Table 132. Mankind Pharma Anthelmintic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 133. Mankind Pharma Anthelmintic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Mankind Pharma Recent Developments
Table 135. Johnson & Johnson Corporation Information
Table 136. Johnson & Johnson Description and Major Businesses
Table 137. Johnson & Johnson Anthelmintic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 138. Johnson & Johnson Anthelmintic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Johnson & Johnson Recent Developments
Table 140. Merck Corporation Information
Table 141. Merck Description and Major Businesses
Table 142. Merck Anthelmintic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 143. Merck Anthelmintic Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Merck Recent Developments
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Anthelmintic Drugs Distributors List
Table 148. Anthelmintic Drugs Customers List
Table 149. Anthelmintic Drugs Market Trends
Table 150. Anthelmintic Drugs Market Drivers
Table 151. Anthelmintic Drugs Market Challenges
Table 152. Anthelmintic Drugs Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Anthelmintic Drugs Product Picture
Figure 3. Global Anthelmintic Drugs Market Share by Type in 2021 & 2028
Figure 3. Oral Drugs Product Picture
Figure 4. Injectables Product Picture
Figure 5. Global Anthelmintic Drugs Market Share by Application in 2021 & 2028
Figure 6. For Human
Figure 7. For Animal
Figure 8. Anthelmintic Drugs Report Years Considered
Figure 9. Global Anthelmintic Drugs Sales 2017-2028 (K Units)
Figure 10. Global Anthelmintic Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Anthelmintic Drugs Revenue 2017-2028 (US$ Million)
Figure 12. Global Anthelmintic Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Anthelmintic Drugs Sales Market Share by Region (2017-2022)
Figure 14. Global Anthelmintic Drugs Sales Market Share by Region (2023-2028)
Figure 15. North America Anthelmintic Drugs Sales YoY (2017-2028) & (K Units)
Figure 16. North America Anthelmintic Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Anthelmintic Drugs Sales YoY (2017-2028) & (K Units)
Figure 18. Europe Anthelmintic Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Anthelmintic Drugs Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific Anthelmintic Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Anthelmintic Drugs Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America Anthelmintic Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Anthelmintic Drugs Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa Anthelmintic Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Anthelmintic Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Anthelmintic Drugs in the World: Market Share by Anthelmintic Drugs Revenue in 2021
Figure 27. Global Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Anthelmintic Drugs Sales Market Share by Type (2017-2028)
Figure 29. Global Anthelmintic Drugs Revenue Market Share by Type (2017-2028)
Figure 30. Global Anthelmintic Drugs Sales Market Share by Application (2017-2028)
Figure 31. Global Anthelmintic Drugs Revenue Market Share by Application (2017-2028)
Figure 32. North America Anthelmintic Drugs Sales Market Share by Type (2017-2028)
Figure 33. North America Anthelmintic Drugs Revenue Market Share by Type (2017-2028)
Figure 34. North America Anthelmintic Drugs Sales Market Share by Application (2017-2028)
Figure 35. North America Anthelmintic Drugs Revenue Market Share by Application (2017-2028)
Figure 36. North America Anthelmintic Drugs Sales Share by Country (2017-2028)
Figure 37. North America Anthelmintic Drugs Revenue Share by Country (2017-2028)
Figure 38. U.S. Anthelmintic Drugs Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Anthelmintic Drugs Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Anthelmintic Drugs Sales Market Share by Type (2017-2028)
Figure 41. Europe Anthelmintic Drugs Revenue Market Share by Type (2017-2028)
Figure 42. Europe Anthelmintic Drugs Sales Market Share by Application (2017-2028)
Figure 43. Europe Anthelmintic Drugs Revenue Market Share by Application (2017-2028)
Figure 44. Europe Anthelmintic Drugs Sales Share by Country (2017-2028)
Figure 45. Europe Anthelmintic Drugs Revenue Share by Country (2017-2028)
Figure 46. Germany Anthelmintic Drugs Revenue (2017-2028) & (US$ Million)
Figure 47. France Anthelmintic Drugs Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Anthelmintic Drugs Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Anthelmintic Drugs Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Anthelmintic Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Anthelmintic Drugs Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Anthelmintic Drugs Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Anthelmintic Drugs Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Anthelmintic Drugs Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Anthelmintic Drugs Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Anthelmintic Drugs Revenue Share by Region (2017-2028)
Figure 57. China Anthelmintic Drugs Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Anthelmintic Drugs Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Anthelmintic Drugs Revenue (2017-2028) & (US$ Million)
Figure 60. India Anthelmintic Drugs Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Anthelmintic Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. Taiwan Anthelmintic Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Anthelmintic Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Anthelmintic Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Anthelmintic Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Philippines Anthelmintic Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Anthelmintic Drugs Sales Market Share by Type (2017-2028)
Figure 68. Latin America Anthelmintic Drugs Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Anthelmintic Drugs Sales Market Share by Application (2017-2028)
Figure 70. Latin America Anthelmintic Drugs Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Anthelmintic Drugs Sales Share by Country (2017-2028)
Figure 72. Latin America Anthelmintic Drugs Revenue Share by Country (2017-2028)
Figure 73. Mexico Anthelmintic Drugs Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Anthelmintic Drugs Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Anthelmintic Drugs Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Anthelmintic Drugs Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Anthelmintic Drugs Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Anthelmintic Drugs Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Anthelmintic Drugs Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Anthelmintic Drugs Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Anthelmintic Drugs Revenue Share by Country (2017-2028)
Figure 82. Turkey Anthelmintic Drugs Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Anthelmintic Drugs Revenue (2017-2028) & (US$ Million)
Figure 84. U.A.E Anthelmintic Drugs Revenue (2017-2028) & (US$ Million)
Figure 85. Anthelmintic Drugs Value Chain
Figure 86. Anthelmintic Drugs Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
Industry Market Size
